NCT06097299 · Interventional trial
A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
Overall registry status Completed
Phase 2
Conditions Respiratory Syncytial Virus
Delaware Valley sites
- DM Clinical Research - Philadelphia · Philadelphia, PA · Philadelphia County
- The Children's Hospital of Philadelphia - Pediatrics · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory